AU Patent

AU353834S — Inhaler

Assigned to Glaxo Group Ltd · Expires 2014-02-24 · 12y expired

What this patent protects

Those features of the inhaler depicted in the representations that are new and distinctive are the shape and/or configuration and/or ornamentation of the labels applied to the inhaler.

USPTO Abstract

Those features of the inhaler depicted in the representations that are new and distinctive are the shape and/or configuration and/or ornamentation of the labels applied to the inhaler.

Drugs covered by this patent

umeclidinium-bromide (UMECLIDINIUM BROMIDE)

Patent Metadata

Patent number: AU353834S
Jurisdiction: AU
Classification: —
Expires: 2014-02-24
Drug substance claim: No
Drug product claim: No
Assignee: Glaxo Group Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.